Search Results - "Ramiro, Sofia"
-
1
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Published in Annals of the rheumatic diseases (01-01-2023)“…To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of axial spondyloarthritis (axSpA)…”
Get more information
Journal Article -
2
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Published in Annals of the rheumatic diseases (01-05-2018)“…To develop evidence-based recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV) including giant cell arteritis (GCA) and…”
Get more information
Journal Article -
3
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein et al
Published in Annals of the rheumatic diseases (01-07-2023)Get more information
Journal Article -
4
Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations
Published in Rheumatic & musculoskeletal diseases open (01-02-2018)“…ObjectivesTo perform a systematic literature review on imaging techniques for diagnosis, outcome prediction and disease monitoring in large vessel vasculitis…”
Get full text
Journal Article -
5
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Published in Annals of the rheumatic diseases (01-09-2020)“…To prospectively investigate in patients with severe COVID-19-associated cytokine storm syndrome (CSS) whether an intensive course of glucocorticoids with or…”
Get more information
Journal Article -
6
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update
Published in Annals of the rheumatic diseases (01-06-2024)“…To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV). A systematic literature review update was…”
Get more information
Journal Article -
7
Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts
Published in Annals of the rheumatic diseases (01-11-2019)“…Patients with spondyloarthritis with radiographic sacroiliitis are traditionally classified according to the modified New York (mNY) criteria as ankylosing…”
Get more information
Journal Article -
8
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Published in Annals of the rheumatic diseases (01-01-2023)“…To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with axial spondyloarthritis (axSpA) to…”
Get more information
Journal Article -
9
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al
Published in Annals of the rheumatic diseases (01-02-2023)Get more information
Journal Article -
10
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Published in Annals of the rheumatic diseases (01-03-2014)“…To update the evidence for the safety of synthetic disease-modifying antirheumatic drugs (sDMARDs), glucocorticoids (GC) and biological DMARDs (bDMARDs) in…”
Get more information
Journal Article -
11
Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort
Published in Annals of the rheumatic diseases (01-02-2018)“…To compare the CT Syndesmophyte Score (CTSS) for low-dose CT (ldCT) with the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) for conventional…”
Get more information
Journal Article -
12
What is a response in randomised controlled trials in giant cell arteritis?
Published in Annals of the rheumatic diseases (01-07-2023)“…Glucocorticoids (GCs) are the gold standard for treatment of giant cell arteritis (GCA); however, there is a need for studies on GC-sparing agents, given that…”
Get more information
Journal Article -
13
-
14
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
Published in Annals of the rheumatic diseases (01-03-2014)“…To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARD) in patients with rheumatoid arthritis (RA) to inform the…”
Get more information
Journal Article -
15
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
Published in Annals of the rheumatic diseases (01-08-2014)“…To analyse the long-term relationship between disease activity and radiographic damage in the spine in patients with ankylosing spondylitis (AS). Patients from…”
Get more information
Journal Article -
16
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Published in Annals of the rheumatic diseases (01-01-2023)“…To update the evidence of non-biological treatments for axial spondyloarthritis (axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international…”
Get more information
Journal Article -
17
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2022)“…Objective To assess the long‐term safety, tolerability, and efficacy of bimekizumab in patients with active ankylosing spondylitis (AS). Methods Patients with…”
Get full text
Journal Article -
18
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis
Published in Annals of the rheumatic diseases (01-06-2017)“…To assess the safety of synthetic (s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) for the management of rheumatoid arthritis (RA) to…”
Get more information
Journal Article -
19
Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort
Published in Annals of the rheumatic diseases (01-11-2017)“…To estimate sacroiliac joint radiographic (X-SIJ) progression in patients with axial spondyloarthritis (axSpA) and to evaluate the effects of inflammation on…”
Get more information
Journal Article -
20
What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts
Published in Annals of the rheumatic diseases (01-03-2020)“…To gain expert-judgement-free insight into the of axial spondyloarthritis (axSpA), by investigating its 'latent constructs' and to test how well these latent…”
Get more information
Journal Article